We are live on ! Find out more
NITE

Nightstar Therapeutics plc American Depositary Shares
NITE

Delisted

NITE was delisted on the 6th of June, 2019.

23 hedge funds and large institutions have $129M invested in Nightstar Therapeutics plc American Depositary Shares in 2018 Q2 according to their latest regulatory filings, with 5 funds opening new positions, 7 increasing their positions, 5 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

150% more first-time investments, than exits

New positions opened: 5 | Existing positions closed: 2

40% more repeat investments, than reductions

Existing positions increased: 7 | Existing positions reduced: 5

15% more funds holding

Funds holding: 2023 (+3)

9% more capital invested

Capital invested by funds: $118M → $129M (+$11.2M)

Holders
23
Holders Change
+3
Holders Change %
+15%
% of All Funds
0.53%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.02%
New
5
Increased
7
Reduced
5
Closed
2
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
Wellington Management Group
1
Wellington Management Group
Massachusetts
$50.6M -$3.65M -255,993 -7%
RG
2
Redmile Group
California
$28.6M +$235K +16,500 +0.9%
PHS
3
PFM Health Sciences
California
$16.3M +$99.9K +7,007 +0.7%
NMC
4
NEA Management Company
Maryland
$11.4M
Ameriprise
5
Ameriprise
Minnesota
$6.91M -$113K -7,910 -2%
WIM
6
Woodford Investment Management
United Kingdom
$5.02M +$4.48M +314,000 New
AC
7
Ascend Capital
California
$2.43M +$438K +30,710 +25%
Alyeska Investment Group
8
Alyeska Investment Group
Illinois
$2.05M +$58.4K +4,093 +3%
EIM
9
Essex Investment Management
Massachusetts
$1.95M
USAA
10
United Services Automobile Association
Texas
$1.1M
CIP
11
Chartwell Investment Partners
Pennsylvania
$729K -$58.8K -4,119 -8%
Millennium Management
12
Millennium Management
New York
$570K +$4.92K +345 +1%
PCM
13
Prelude Capital Management
New York
$547K
UOC
14
UBS O'Connor
Illinois
$448K +$399K +27,978 New
SLG
15
Stanley-Laman Group
Pennsylvania
$195K +$174K +12,181 New
PIM
16
Partner Investment Management
California
$152K -$12.7K -889 -9%
Bank of America
17
Bank of America
North Carolina
$132K +$117K +8,235 New
UBS Group
18
UBS Group
Switzerland
$102K +$87.9K +6,161 +3,348%
Royal Bank of Canada
19
Royal Bank of Canada
Ontario, Canada
$28K +$4.18K +293 +20%
Citigroup
20
Citigroup
New York
$16K -$14.3K -1,000 -50%
Wells Fargo
21
Wells Fargo
California
$5K
PA
22
Parallel Advisors
California
$4K
Morgan Stanley
23
Morgan Stanley
New York
$4K +$3.18K +223 New
TCP
24
Tourbillon Capital Partners
New York
-$2.45M -170,952 Closed
Franklin Resources
25
Franklin Resources
California
-$1.96M -136,387 Closed

NITE Hedge Fund Activity: Q2 2018 in Review

23 of the 4,368 institutional investors tracked by Wall St. Rank reported a position in Nightstar Therapeutics plc American Depositary Shares (NITE) for Q2 2018, worth a combined $129M — up 9.5% from $118M a quarter earlier.

Buyers outnumbered sellers: 5 funds opened new NITE positions and 2 closed out — a net gain of 3 holders — while 7 added to existing stakes and 5 trimmed.

The largest buyer was Woodford Investment Management, opening a new position worth an estimated $4.48M. The largest seller was Wellington Management Group, cutting an estimated $3.65M.

  • 23 institutional investors held Nightstar Therapeutics plc American Depositary Shares (NITE) as of Q2 2018, up from 20 in Q1 2018.
  • Funds reported $129M of Nightstar Therapeutics plc American Depositary Shares stock for Q2 2018, up 9.5% quarter-over-quarter.
  • 5 funds opened new Nightstar Therapeutics plc American Depositary Shares positions in Q2 2018 and 2 closed out, a net change of +3 holders.
  • The largest Nightstar Therapeutics plc American Depositary Shares buyer in Q2 2018 was Woodford Investment Management, an estimated $4.48M added.
  • The largest Nightstar Therapeutics plc American Depositary Shares seller in Q2 2018 was Wellington Management Group, an estimated $3.65M sold.

Based on aggregated 13F filings for Q2 2018.